Published in Cancer Epidemiol Biomarkers Prev on February 21, 2012
REN-Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors | NCT03185546
Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med (2015) 3.63
Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med (2014) 1.88
Reducing the nicotine content to make cigarettes less addictive. Tob Control (2013) 1.60
Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev (2013) 1.37
Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev (2012) 1.34
Nicotine reduction: strategic research plan. Nicotine Tob Res (2012) 1.27
Dose-response effects of spectrum research cigarettes. Nicotine Tob Res (2012) 1.22
Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach. Prev Med (2014) 1.11
Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. Addiction (2015) 1.10
Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev (2014) 1.00
Large-scale unassisted smoking cessation over 50 years: lessons from history for endgame planning in tobacco control. Tob Control (2013) 0.99
Gradual and immediate nicotine reduction result in similar low-dose nicotine self-administration. Nicotine Tob Res (2013) 0.96
Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure. Addiction (2012) 0.94
Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy. Pharmacol Biochem Behav (2013) 0.94
Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products. Tob Control (2013) 0.90
Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes. Nicotine Tob Res (2013) 0.89
Sex differences in response to reduced nicotine content cigarettes. Addict Behav (2014) 0.89
Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy. Drug Alcohol Depend (2015) 0.87
Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms. Nicotine Tob Res (2016) 0.86
Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes. Addiction (2016) 0.83
Mouth-level intake of benzo[a]pyrene from reduced nicotine cigarettes. Int J Environ Res Public Health (2014) 0.83
Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev (2014) 0.83
A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings. Cancer Epidemiol Biomarkers Prev (2016) 0.83
Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes. Nicotine Tob Res (2015) 0.79
Scientific overview: 2013 BBC plenary symposium on tobacco addiction. Drug Alcohol Depend (2014) 0.79
The predicted impact of reducing the nicotine content in cigarettes on alcohol use. Nicotine Tob Res (2014) 0.78
The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use. Alcohol Clin Exp Res (2016) 0.78
Public opinion about FDA regulation of menthol and nicotine. Tob Control (2014) 0.78
Preliminary Evaluation of a New German Translated Tobacco Quality of Life Impact Tool to Discriminate Between Healthy Current and Former Smokers and to Explore the Effect of Switching Smokers to a Reduced Toxicant Prototype Cigarette. Nicotine Tob Res (2015) 0.77
Reduced Nicotine Content Expectancies Affect Initial Responses to Smoking. Tob Regul Sci (2016) 0.77
Comparison of nicotine dependence indicators in predicting quitting among pregnant smokers. Exp Clin Psychopharmacol (2016) 0.77
The tobacco endgame: a qualitative review and synthesis. Tob Control (2015) 0.76
Attrition during a randomized controlled trial of reduced nicotine content cigarettes as a proxy for understanding acceptability of nicotine product standards. Addiction (2017) 0.75
Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial. Addiction (2016) 0.75
Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior. Drug Alcohol Depend (2017) 0.75
Use of High-Nicotine/Tar-Yield (Full-Flavor) Cigarettes and Risk for Nicotine Dependence in Nationally Representative Samples of US Smokers. Nicotine Tob Res (2015) 0.75
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. BMC Public Health (2017) 0.75
Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers. Tob Control (2014) 0.75
Very low nicotine content cigarettes and potential consequences on cardiovascular disease. Curr Cardiovasc Risk Rep (2012) 0.75
Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. Neuropsychopharmacology (2017) 0.75
Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research. Psychopharmacology (Berl) (2016) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol (1983) 37.48
Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry (1986) 10.11
Smoking cessation and severity of weight gain in a national cohort. N Engl J Med (1991) 6.84
Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med (1994) 6.75
Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol (2008) 4.26
Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr (1981) 3.72
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis (2002) 3.49
Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tob Control (1998) 3.47
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction (2010) 3.26
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev (2007) 2.43
Nicotine reduction revisited: science and future directions. Tob Control (2010) 2.41
Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther (2006) 2.35
Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom (1991) 2.10
The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts. Prev Med (2005) 1.73
Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem (2007) 1.69
Classification and prediction of smoking relapse episodes: an exploration of individual differences. J Consult Clin Psychol (1988) 1.55
Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiol Biomarkers Prev (2005) 1.31
Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav (1999) 1.30
Reduced-nicotine content cigarettes: Is there potential to aid smoking cessation? Nicotine Tob Res (2009) 1.26
Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control (2013) 7.69
Metabolism and disposition kinetics of nicotine. Pharmacol Rev (2005) 6.66
Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol (2009) 4.16
A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol (2004) 4.02
Thirdhand tobacco smoke: emerging evidence and arguments for a multidisciplinary research agenda. Environ Health Perspect (2011) 3.69
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther (2004) 3.49
Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther (2002) 3.36
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation (2002) 3.08
Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol (2004) 2.93
Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards. Proc Natl Acad Sci U S A (2010) 2.93
Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther (2006) 2.71
Reaching young adult smokers through the internet: comparison of three recruitment mechanisms. Nicotine Tob Res (2010) 2.47
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev (2007) 2.43
Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther (2006) 2.35
Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation (2005) 2.21
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clin Pharmacol Ther (2006) 2.21
Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol (2012) 2.01
Drinking water as a proportion of total human exposure to volatile N-nitrosamines. Risk Anal (2013) 1.97
Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med (2005) 1.94
Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women. Cancer (2002) 1.90
Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. Crit Care Med (2011) 1.86
Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst (2002) 1.83
Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol (2004) 1.82
Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat Genet (2001) 1.82
Evaluating the validities of different DSM-IV-based conceptual constructs of tobacco dependence. Addiction (2008) 1.80
Nicotine, carbon monoxide, and carcinogen exposure after a single use of a water pipe. Cancer Epidemiol Biomarkers Prev (2011) 1.78
Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med (2009) 1.78
Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther (2004) 1.77
Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant (2002) 1.77
Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res (2003) 1.76
Reliability and validity of self-reported smoking in an anonymous online survey with young adults. Health Psychol (2011) 1.74
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem (2007) 1.69
Depressed smokers and stage of change: implications for treatment interventions. Drug Alcohol Depend (2004) 1.64
Food security, maternal stressors, and overweight among low-income US children: results from the National Health and Nutrition Examination Survey (1999-2002). Pediatrics (2008) 1.63
Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther (2002) 1.63
Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res (2011) 1.61
Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol (2005) 1.58
Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 1.58
Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev (2009) 1.53
Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening. Am J Epidemiol (2009) 1.52
Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res (2011) 1.50
Cystic primary pulmonary synovial sarcoma presenting as recurrent pneumothorax: report of 4 cases. Am J Surg Pathol (2010) 1.49
Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict (2006) 1.49
A California sea lion (Zalophus californianus) can keep the beat: motor entrainment to rhythmic auditory stimuli in a non vocal mimic. J Comp Psychol (2013) 1.48
Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48
Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public Health (2007) 1.46
GHB urine concentrations after single-dose administration in humans. J Anal Toxicol (2006) 1.45
Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenet Genomics (2005) 1.43
Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther (2006) 1.41
Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health (2013) 1.38
Comparison of nicotine and carcinogen exposure with water pipe and cigarette smoking. Cancer Epidemiol Biomarkers Prev (2013) 1.37
Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure. Nicotine Tob Res (2009) 1.36
Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol (2005) 1.36
Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res (2005) 1.36
Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv (2004) 1.35
Comparing intervention outcomes in smokers treated for single versus multiple behavioral risks. Health Psychol (2006) 1.35
Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev (2012) 1.34
Factors associated with hepatitis B testing among Vietnamese Americans. J Gen Intern Med (2010) 1.33
Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries. Pulm Circ (2011) 1.31
Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiol Biomarkers Prev (2005) 1.31
Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci (2010) 1.30
Attitudes and practices of hookah smokers in the San Francisco Bay Area. J Psychoactive Drugs (2011) 1.29
Progress in the pipeline: replication of the minority training program in cancer control research. J Cancer Educ (2006) 1.29
The effect of access and satisfaction on regular mammogram and Papanicolaou test screening in a multiethnic population. Med Care (2004) 1.26
Access and attitudinal factors related to breast and cervical cancer rescreening: why are Latinas still underscreened? Health Educ Behav (2003) 1.26
The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer. Prev Med (2005) 1.24
Can the Iowa Satisfaction with Anesthesia Scale be used to measure patient satisfaction with cataract care under topical local anesthesia and monitored sedation at a community hospital? Anesth Analg (2005) 1.24
Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial. Prev Med (2008) 1.21
Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: a round-robin study. Nicotine Tob Res (2009) 1.21
What determines patient satisfaction with cataract care under topical local anesthesia and monitored sedation in a community hospital setting? Anesth Analg (2005) 1.20
The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant (2011) 1.20
Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophr Bull (2007) 1.20
Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant (2004) 1.20
Longer term exposure to secondhand smoke and health outcomes in COPD: impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Nicotine Tob Res (2009) 1.20
Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol (2012) 1.17
Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev (2009) 1.17
The Smoking Abstinence Questionnaire: measurement of smokers' abstinence-related expectancies. Addiction (2011) 1.17
Marijuana and tobacco co-use in young adults: patterns and thoughts about use. J Stud Alcohol Drugs (2013) 1.16
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant (2008) 1.16
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2013) 1.16
Pharmacotherapy for smoking cessation during pregnancy. Nicotine Tob Res (2004) 1.15
Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence. Drug Alcohol Depend (2010) 1.15
Thirdhand smoke causes DNA damage in human cells. Mutagenesis (2013) 1.14